Cirius Therapeutics, Inc., 2025-10-08
An SEC Form D private-offering notice from Grand Rapids, MI, a $1,200,000 filer-stated offering target in Biotech. Filed 2025-10-08. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage pharmaceutical company developing oral insulin-sensitizer therapies (lead candidate azemiglitazone/MSDC-0602K, a mitochondrial pyruvate carrier modulator) for metabolic diseases including type 2 diabetes, obesity, and NASH.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- SportsCaster Media LLC, 2025-10-31, $1.5M, Birmingham, MI
- Rinascera Therapeutics, Inc., 2025-10-08, $2.5M, Boston, MA
- ORBION SPACE TECHNOLOGY, INC., 2025-10-29, $3M, Houghton, MI
- Mati Therapeutics Inc., 2025-10-08, $10.5M, Austin, TX
- NxLite Technologies Inc., 2025-10-27, $9.5M, Canton, MI
- ThirdLaw Molecular, Inc., 2025-10-08, $5.5M, Blue Bell, PA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.